121 related articles for article (PubMed ID: 7444140)
21. Phase II trial of pirarubicin in the treatment of advanced pancreatic cancer.
Mahjoubi M; Rougier P; Oliviera J; Herait P; Tigaud JM; Droz JP
Cancer Invest; 1994; 12(4):403-5. PubMed ID: 8032961
[TBL] [Abstract][Full Text] [Related]
22. Phase II clinical evaluation of 4'-epi-doxorubicin.
Hurteloup P; Cappelaere P; Armand JP; Mathé G
Cancer Treat Rep; 1983 Apr; 67(4):337-41. PubMed ID: 6573956
[TBL] [Abstract][Full Text] [Related]
23. Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study.
Jehn CF; Hemmati P; Lehenbauer-Dehm S; Kümmel S; Flath B; Schmid P
Clin Breast Cancer; 2016 Dec; 16(6):514-519. PubMed ID: 27395417
[TBL] [Abstract][Full Text] [Related]
24. Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review).
Orditura M; Quaglia F; Morgillo F; Martinelli E; Lieto E; De Rosa G; Comunale D; Diadema MR; Ciardiello F; Catalano G; De Vita F
Oncol Rep; 2004 Sep; 12(3):549-56. PubMed ID: 15289836
[TBL] [Abstract][Full Text] [Related]
25. Preliminary phase I study of 4'-epi-adriamycin.
Bonfante V; Bonadonna G; Villani F; Di Fronzo G; Martini A; Casazza AM
Cancer Treat Rep; 1979 May; 63(5):915-8. PubMed ID: 455333
[TBL] [Abstract][Full Text] [Related]
26. Anthracycline analogs: re-assessments and prospects.
Carter SK
Cancer Treat Rep; 1979 May; 63(5):935-6. PubMed ID: 455336
[No Abstract] [Full Text] [Related]
27. [Liposomal doxorubicin in patients with breast cancer and concomitant cardiovascular diseases - interdisciplinary expert opinion].
Szmit S; Filipiak KJ; Litwiniuk M; Opolski G; Wysocki P; Zaborska B; Krzakowski M
Kardiol Pol; 2016; 74(9):1031-6. PubMed ID: 27654476
[TBL] [Abstract][Full Text] [Related]
28. Preliminary evaluation of a phase I clinical study of quelamycin.
Cortés H; Vicente J; Baena L; Otero J; Gosálvez M
Eur J Cancer (1965); 1978 Dec; 14(12):1359-61. PubMed ID: 738339
[No Abstract] [Full Text] [Related]
29. Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin?
Köseoğlu V; Berberoğlu S; Karademir S; Kismet E; Yurttutan N; Demirkaya E; Sungur M; Alehan D
Turk J Pediatr; 2005; 47(1):17-22. PubMed ID: 15884624
[TBL] [Abstract][Full Text] [Related]
30. The anthracyclines: will we ever find a better doxorubicin?
Weiss RB
Semin Oncol; 1992 Dec; 19(6):670-86. PubMed ID: 1462166
[TBL] [Abstract][Full Text] [Related]
31. DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials.
Kratz F
Expert Opin Investig Drugs; 2007 Jun; 16(6):855-66. PubMed ID: 17501697
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of deoxydoxorubicin in patients with advanced liver cancer.
Perry DJ; Van Echo DA; Mick R
Cancer Treat Rep; 1987 Nov; 71(11):1117-8. PubMed ID: 3119209
[No Abstract] [Full Text] [Related]
33. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.
Hayakawa H; Komada Y; Hirayama M; Hori H; Ito M; Sakurai M
Med Pediatr Oncol; 2001 Jul; 37(1):4-9. PubMed ID: 11466716
[TBL] [Abstract][Full Text] [Related]
34. Adriamycin-induced myocardial toxicity: new solutions for an old problem?
Outomuro D; Grana DR; Azzato F; Milei J
Int J Cardiol; 2007 Apr; 117(1):6-15. PubMed ID: 16863672
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin-induced second degree and complete atrioventricular block.
Kilickap S; Akgul E; Aksoy S; Aytemir K; Barista I
Europace; 2005 May; 7(3):227-30. PubMed ID: 15878560
[TBL] [Abstract][Full Text] [Related]
36. Aronex Pharmaceuticals reports on annamycin phase I trial.
Expert Rev Anticancer Ther; 2001 Jun; 1(1):4. PubMed ID: 12113129
[No Abstract] [Full Text] [Related]
37. Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes.
Tahover E; Patil YP; Gabizon AA
Anticancer Drugs; 2015 Mar; 26(3):241-58. PubMed ID: 25415656
[TBL] [Abstract][Full Text] [Related]
38. [Acute cardiogenic postoperative edema after doxorubicin (adriamycin) chemotherapy].
Boulay G; Debaene B
Ann Fr Anesth Reanim; 1998; 17(1):43-6. PubMed ID: 9750682
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
Campora E; Nobile MT; Sertoli MR; Rosso R
Cancer Treat Rep; 1984 Oct; 68(10):1285-6. PubMed ID: 6597003
[No Abstract] [Full Text] [Related]
40. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.
Pein F; Sakiroglu O; Dahan M; Lebidois J; Merlet P; Shamsaldin A; Villain E; de Vathaire F; Sidi D; Hartmann O
Br J Cancer; 2004 Jul; 91(1):37-44. PubMed ID: 15162142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
